2021 annual financial data
ImmunityBio 2021 Operating cash flow
ImmunityBio 2021 operating cash flow with verified reported values.
Direct answer
Operating cash flow was -274,419,000 USD.
Operating income was -330,280,000 USD and net income was -346,790,000 USD.
Operating cash flow was -274,419,000 USD.
Get free ImmunityBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 934,000 USD
- Operating income
- -330,280,000 USD
- Net income
- -346,790,000 USD
- Operating cash flow
- -274,419,000 USD